ABIONYX Pharma SA

France

Commandez votre montre hebdomadaire ABIONYX Pharma SA
Quantité totale PI 48
Rang # Quantité totale PI 29 472
Note d'activité PI 2,6/5.0    49
Rang # Activité PI 14 766
Symbole boursier
ISIN FR0012616852
Capitalisation 46.2M  (EUR)
Industrie Biotechnology
Secteur Healthcare

Brevets

Marques

24 0
10 0
14 0
0
 
Dernier brevet 2025 - Methods for treating hyperinflam...
Premier brevet 2013 - Lipoprotein complexes and manufa...

Derniers inventions, produits et services

2025 Invention Cer-001 therapy for treating kidney disease. CER-001 for treating kidney disease, and methods fo...
Invention Lipoprotein complexes and manufacturing and uses thereof. The present disclosure relates to lipo...
Invention Compounds useful for treating liver diseases. This invention provides compounds, for example, of...
2024 Invention Lipid binding protein molecule therapy. Methods for treating subjects having or at risk of one or...
2023 Invention Lipoprotein complexes and manufacturing and uses thereof. The present disclosure relates to lipop...
Invention Apomers. Apomers comprising apolipoprotein molecules complexed with amphipathic molecules and us...
Invention Cer-001 therapy for treating kidney disease. Disclosed herein is the use of CER-001, a negatively...
Invention Compounds and processes for the synthesis of sphingomyelins. NDerythroerythro-sphingomyelin, nove...
Invention Compounds and processes for the synthesis of sphingomyelins
Invention Methods for treating hyperinflammatory conditions using lipid binding protein -based complexes. ...
Invention Methods for treating hyperinflammatory conditions using lipid binding protein -based complexes. M...
Invention Methods for treating acute conditions using lipid binding protein-based complexes. Methods for tr...
Invention Methods for treating hyperinflammatory conditions using lipid binding protein -based complexes
Invention Methods for treating acute conditions using lipid binding protein-based complexes
Invention Methods for treating leukocytosis, endothelial dysfunction and carditis using lipid binding prote...
Invention Methods for treating eye diseases using lipid binding protein-based complexes. Disclosed herein ...
Invention Methods for treating eye diseases using lipid binding protein-based complexes. Disclosed herein a...
Invention Compounds useful for treating liver diseases. This invention provides compounds, for example, of ...
2022 Invention Complexes for delivery of cyclic dinucleotides. Lipid binding protein based complexes for carryin...
Invention Use of lipid binding protein-based complexes in organ preservation solutions. Lipid binding prot...
Invention Use of lipid binding protein-based complexes in organ preservation solutions. Lipid binding prote...
2021 Invention Methods for treating eye diseases using lipid binding protein-based complexes. Methods for treat...
Invention Compositions comprising lipid binding protein-based complexes for use for treating eye diseases. ...
Invention Methods for treating eye diseases using lipid binding protein-based complexes. Methods for treati...
Invention Methods for treating acute conditions using lipid binding protein-based complexes. Methods for t...
Invention Cer-001 therapy for treating kidney disease. CER-001 for treating kidney disease, and methods for...
Invention Methods for treating acute conditions using lipid binding protein- based complexes. e.g.e.g., acu...
Invention Cer-001 therapy for treating kidney disease. Methods for treating a subject having kidney disease...
2020 Invention Compounds useful for treating liver diseases. This invention provides compounds of Formulae (A) ...
Invention Compounds useful for treating liver diseases. This invention provides compounds of Formulae (A) a...
2017 Invention Charged lipoprotein complexes and their uses. The present disclosure provides charged lipoprotein...